Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its target price hoisted by equities research analysts at HC Wainwright from $17.00 to $19.00 in a report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 248.62% from the stock’s […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report)’s share price dropped 6% during trading on Monday . The company traded as low as $7.25 and last traded at $7.25. Approximately 249,563 shares changed hands during trading, a decline of 80% from the average daily volume of 1,219,567 shares. The stock had previously closed at $7.71. […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) shares were down 6% during trading on Monday . The company traded as low as $7.25 and last traded at $7.25. Approximately 249,563 shares were traded during trading, a decline of 80% from the average daily volume of 1,219,567 shares. The stock had previously closed at $7.71. […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $7.57, but opened at $7.11. Travere Therapeutics shares last traded at $7.87, with a volume of 211,116 shares trading hands. Analyst Upgrades and Downgrades Several research analysts have recently commented on TVTX […]
Profund Advisors LLC cut its position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 32.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 60,983 shares of the company’s stock after selling 28,947 shares during the period. Profund Advisors […]